Catalog Peptides Market Leaders, Segment Analysis and Development, Forecast Report 2024

The catalog peptides market is expected to grow to $332.1 million by 2024 at a CAGR of 5.8% during the forecast period.

The catalog peptides market is observing growth due to advancements in technology that help in the cost-effective manufacturing of peptides. Previously, peptides were synthesized from natural sources, such as adrenocorticotropic hormone (ACTH) derived from the porcine or bovine pituitary and insulin from bovine or canine pancreas. The production of naturally synthesized peptides is not only time consuming, but also has low yield and is much more cost-intensive. With technical advancements, peptides, such as octreotide, oxytocin, leuprorelin, and vasopressin, can be synthesized using solid-phase synthesis.

Download sample copy of this report at: https://www.psmarketresearch.com/market-analysis/catalog-peptides-market/report-sample

Another major contributing factor in the catalog peptides market growth is the rising chronic disease burden. As the prevalence of such diseases is increasing across the globe, the demand for effective therapeutics is witnessing a surge. A report by the Joint United Nations Programme on HIV/AIDS estimated that about 36.9 million people in 2017 lived with HIV infection. Further, the American Heart Association mentioned in its 2018 factsheet that due to cardiovascular diseases, 836,546 deaths occurred in the U.S. Owing to the low immunogenicity and toxicity of catalog peptides, they are in high demand for treating such conditions.

The catalog peptides market is segmented by region, type, end user, and application. Based on end user, the categories are academic & research institutes, pharmaceutical & biotechnology companies, and contract manufacturing organizations (CMOs) and contract research organizations (CROs). In 2018, the largest revenue share in the market was held by pharmaceutical & biotechnology companies, which is projected to account for the highest revenue generation in the forecast period. This is because of their increasing use as therapeutics due to their better chemical diversity and affinity when compared to other biological molecules.

Explore full report at: https://www.psmarketresearch.com/market-analysis/catalog-peptides-market

Asia-Pacific (APAC) can be the most lucrative region for the catalog peptides market to maximize revenue. A 2017 United Nations factsheet mentioned that the population above the age of 60 would double by 2050 across the globe. With the rising prevalence of chronic diseases, the demand for novel therapies is increasing for the proper management of such diseases. As the APAC region accounts for 60.0% of the world’s population, the demand for catalog peptides is expected to be high here. Further, low manufacturing costs and lenient regulations are inviting foreign investments.

Hence, the market for catalog peptides is slated to advance in the forecast period due to the rising chronic disease prevalence, increasing research activities, and technical advancements.

Contact:
P&S Intelligence
Toll-free: +1-888-778-7886 (USA/Canada)
International: +1-347-960-6455
Email: enquiry@psmarketresearch.com
Web: https://www.psmarketresearch.com
Blog: https://healthcarefuturetrends.blogspot.com/

About P&S Intelligence

P&S Intelligence is a provider of market research and consulting services catering to the market information needs of burgeoning industries across the world. Providing the plinth of market intelligence, P&S as an enterprising research and consulting company, believes in providing thorough landscape analyses on the ever-changing market scenario, to empower companies to make informed decisions and base their business strategies with astuteness.

This release was published on openPR.